{"id":4,"date":"2006-02-15T07:15:06","date_gmt":"2006-02-14T23:15:06","guid":{"rendered":"http:\/\/www.chinacsr.com\/2006\/02\/15\/cytodyn-plans-china-hivaids-joint-venture\/"},"modified":"2006-02-15T07:15:06","modified_gmt":"2006-02-14T23:15:06","slug":"cytodyn-plans-china-hivaids-joint-venture","status":"publish","type":"post","link":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/","title":{"rendered":"CytoDyn Plans China HIV\/AIDS Joint Venture"},"content":{"rendered":"<p>CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for HIV\/AIDS.<br \/>\n<!--more--><br \/>\nTimeway International has its principle offices in Phoenix, Hong Kong, Bejing, and Shanghai. It has joined with a select few U.S. biotech firms in order to bring a variety of advanced, non-competing medical technologies to China.<\/p>\n<p>Cytolin is the first targeted immune therapy for HIV\/AIDS that was shown to significantly reduce viral burden in preliminary human studies. The potential advantage is that Cytolin exerts its effect on the immune system and not the virus. As a result, a species of virus resistant to the effects of Cytolin(R) cannot emerge through natural selection because the drug has no effects on the virus itself.<\/p>\n<p>In addition to providing an additional treatment for the disease, Cytolin might extend the useful life of the antiretroviral drugs currently used to treat HIV\/AIDS.<\/p>\n<p>Allen D. Allen, Chairman and CEO of CytoDyn, has given a high priority to helping people who are living with AIDS in the developing nations. The anticipated joint venture between CytoDyn and Timeway is an important step forward in that direction, according to Allen. CytoDyn will be represented in the Asian Markets by its consultant Huey Hua.<\/p>\n<p>The joint venture will still have to be approved by the governments of both the U.S. and China, and neither company has completed its due diligence.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for HIV\/AIDS.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China<\/title>\n<meta name=\"description\" content=\"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn&#039;s targeted immune therapy for\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\" \/>\n<meta property=\"og:description\" content=\"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn&#039;s targeted immune therapy for\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\" \/>\n<meta property=\"og:site_name\" content=\"ChinaCSR.com\" \/>\n<meta property=\"article:published_time\" content=\"2006-02-14T23:15:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CSR and Sustainability Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:site\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CSR and Sustainability Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\"},\"author\":{\"name\":\"CSR and Sustainability Editor\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\"},\"headline\":\"CytoDyn Plans China HIV\/AIDS Joint Venture\",\"datePublished\":\"2006-02-14T23:15:06+00:00\",\"dateModified\":\"2006-02-14T23:15:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\"},\"wordCount\":248,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\",\"name\":\"CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\"},\"datePublished\":\"2006-02-14T23:15:06+00:00\",\"dateModified\":\"2006-02-14T23:15:06+00:00\",\"description\":\"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for\",\"breadcrumb\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chinacsr.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CytoDyn Plans China HIV\/AIDS Joint Venture\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"name\":\"ChinaCSR.com\",\"description\":\"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\",\"name\":\"ChinaCSR.com\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"contentUrl\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"width\":800,\"height\":620,\"caption\":\"ChinaCSR.com\"},\"image\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/China_CSR\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\",\"name\":\"CSR and Sustainability Editor\",\"sameAs\":[\"http:\/\/www.chinacsr.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","description":"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/","og_locale":"en_US","og_type":"article","og_title":"CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","og_description":"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for","og_url":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/","og_site_name":"ChinaCSR.com","article_published_time":"2006-02-14T23:15:06+00:00","og_image":[{"width":800,"height":620,"url":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","type":"image\/jpeg"}],"author":"CSR and Sustainability Editor","twitter_card":"summary_large_image","twitter_creator":"@China_CSR","twitter_site":"@China_CSR","twitter_misc":{"Written by":"CSR and Sustainability Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#article","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/"},"author":{"name":"CSR and Sustainability Editor","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba"},"headline":"CytoDyn Plans China HIV\/AIDS Joint Venture","datePublished":"2006-02-14T23:15:06+00:00","dateModified":"2006-02-14T23:15:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/"},"wordCount":248,"commentCount":0,"publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/","url":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/","name":"CytoDyn Plans China HIV\/AIDS Joint Venture - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/#website"},"datePublished":"2006-02-14T23:15:06+00:00","dateModified":"2006-02-14T23:15:06+00:00","description":"CytoDyn has signed a letter of intent with Timeway International for a joint venture in China to develop Cytolin, CytoDyn's targeted immune therapy for","breadcrumb":{"@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.chinacsr.com\/en\/2006\/02\/15\/4-cytodyn-plans-china-hivaids-joint-venture\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chinacsr.com\/en\/"},{"@type":"ListItem","position":2,"name":"CytoDyn Plans China HIV\/AIDS Joint Venture"}]},{"@type":"WebSite","@id":"https:\/\/www.chinacsr.com\/en\/#website","url":"https:\/\/www.chinacsr.com\/en\/","name":"ChinaCSR.com","description":"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.chinacsr.com\/en\/#organization","name":"ChinaCSR.com","url":"https:\/\/www.chinacsr.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","contentUrl":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","width":800,"height":620,"caption":"ChinaCSR.com"},"image":{"@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/China_CSR"]},{"@type":"Person","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba","name":"CSR and Sustainability Editor","sameAs":["http:\/\/www.chinacsr.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/4","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/comments?post=4"}],"version-history":[{"count":0,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/4\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/media?parent=4"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/categories?post=4"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/tags?post=4"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}